SARS-CoV2 infection (Covid-19) U07.1
Conditions
Interventions
Group 1: Subjects using public transport in the Rhine-Main area, two SARS-CoV-2 tests per visit (day 1 and day 35) each: a PCR test for active SARS-CoV-2 infection and an IgG antibody test to detect p
Sponsors
INFRA Dialog Deutschland GmbH
Eligibility
Sex/Gender
All
Age
16 Years to 65 Years
Inclusion criteria
Inclusion criteria: • Signed informed consent form • Signed statement to abide by applicable public transportation hygiene measures and to wear appropriate mouth/nose cover • Commuters using public transportation or individual transportation daily (5 days) to work, training, or school (car, bicycle, other) • One-way trip by public transit is more than 15 minutes • 16-65 years of age • Willing to use both public transit and individual transportation • Driver's license and car, bicycle, or other individual transportation use • No change in work location, training location, or school location over study period
Exclusion criteria
Exclusion criteria: • Acute SARS-CoV-2 infection - SARS-CoV-2 vaccination • Planned vacation during the study period • Home office
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evidence of acute or recent SARS-CoV-2 infection during the study period | — |
Secondary
| Measure | Time frame |
|---|---|
| Two exploratory goals: 1. Symptomatic and asymptomatic SARS-CoV-2 infections over the observation period 2 Investigation of possible risk factors for SARS-CoV-2 infections | — |
Countries
Germany
Outcome results
None listed